Fatima Bhopalwala Ali¹, Mustafa Ali^2*

¹Assistant Professor, Department of Anatomy} {²Assistant Professor, Department of Pathology} Government Medical College, Ratlam, Madhya Pradesh, INDIA.

Email: dr.mustafa-ali@live.com

REFERENCES

1. Sacchi S, Kantarjian H, O’Brian S, Cortes J, Rios MB, Giles FJ et al.. chronic myeloid leukemia in nonlymphoid blastic phase: analysis of the results of first salvage therapy with three different treatment approaches for 162 patients. Cancer (Phila.). 1999; 86: 2632-41
2. Cortes J, O'Dwyer. Clonal evolution in chronic myeloid leukemia. MEHematol Oncol Clin North Am. 2004 Jun;18(3):671-84.
3. Chang F, Qazi RA, Khan M, Baloch S, Sahito MM (2015) Clinico Hematological Profile and Phase Distribution of Chronic Myeloid Leukemia. Biol Med (Aligarh) 7: 257.
4. Riaz Ahmed, Naeem Naqi, Iftikhar Hussain, Badshah Khan Khattak et al.. Presentating Phases of Chronic Myeloid Leukaemia. Journal of the College of Physicians and Surgeons Pakistan 2009, Vol. 19 (8): 469-472.
5. Kantarjian HM, Smith TL, McCreddie KB et al.. Chronic myeloid leukemia: a multivariate analysis of the associations of patients’ characteristics and therapy with survival. Blood. 1985; 66(6): 1326-35.
6. Marktel S, Marin D, Foot N et al.. Chronic myeloid leukemia in chronic phase responding to imatinib: the occurrence of additional cytogenetic abnormalities predicts disease progression. Haematologica. 2003; 88(3): 260-267.
7. Wang W, Cortes JE, Tang G, et al.. Risk stratification of chromosomal abnormalities in chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy. Blood. 2016;127(22):2742‐2750.
8. Hsiao HH, Liu YC, Tsai HJ, Hsu JF, Yang WC, Chang CS, Lin SF. Additional chromosome abnormalities in chronic myeloid leukemia. Kaohsiung J Med Sci. 2011 Feb;27(2):49-54.
9. Ruchi Sinha, Iffat Jamal, Priyamvada, Punam Prasad Bhadani. Clinico-haematological Profile of Chronic Myeloid Leukaemia: An Institutional Based Study from Bihar. National Journal of Laboratory Medicine. 2019, Jan, Vol-8(2):26-29.
10. Kumar S, Gupta VK, Bharti A, Meena LP, Gupta V, Shukla J. A study to determine the clinical, hematological, cytogenetic, and molecular profile in CML patient in and around Eastern UP, India. J Family Med Prim Care. 2019 Jul;8(7):2450-2455.